ArticlePflugers Archiv : European journal of physiology2008
Impaired acetylcholine-induced smooth muscle contraction in colitis involves altered calcium mobilization and AKT phosphorylation.
Article in Pflugers Archiv : European journal of physiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 5 citations in OpenAlex.
- Jun kinase-induced overexpression of leukemia-associated Rho GEF (LARG) mediates sustained hypercontraction of longitudinal smooth muscle in inflammation.American journal of physiology. Cell physiology · 2014Article
- Antispasmodic effects of yarrow (Achillea millefolium L.) extract in the isolated ileum of rat.African journal of traditional, complementary, and alternative medicines : AJTCAM · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In trinitrobenzene sulphonic acid (TNBS)-induced colitis in the rat, isolated circular smooth muscle cells (CSMC) show decreased contraction to acetylcholine (ACh) but the presence and contribution of altered intracellular signaling is poorly understood. To characterize ACh-induced signaling via calcium and the principal signaling kinases ERK1/2 and AKT in CSMC during colitis, isolated colonic CSMC from control, TNBS-inflamed (day 4) or recovered (day 36) rats were treated with ACh. Intracellular Ca2+ and contraction was determined by fluorescence video microscopy. Total and phosphorylated AKT and ERK1/2 were determined by western blotting. By day 4 of colitis, Ca2+ elevation was both delayed and reduced to less than threefold of control. The time to contraction after ACh was increased threefold, and peak contraction velocity was half that of control, with a marked reduction in calcium mobilization from intracellular stores. In control CSMC, ACh increased pAKT by sixfold over control at 5 s post application but without change in pERK1/2. Inhibition of AKT did not affect the Ca2+ response to ACh but reduced CSMC contraction by an amount similar to that seen in colitis. This, taken with a marked reduction of ACh-induced pAKT in CSMC in colitis, suggests that AKT signaling is an additional target of inflammation leading to impaired contraction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.